Your provider can prescribe them legitimately if you meet certain criteria
And as GPs we need to raise peptide use proactively and without judgement. The University of Queensland researchers say they are most concerned by the burgeoning market of unapproved image and performance-enhancing drugs that is expanding with minimal oversight
Anyone also on testosterone, peptides, or other medications needs that in the clinical record, not left out [2]
Wayne Winegarden, Director, PRI Center for Medical Economics and Innovation, said: GLP-1s are among the most promising medical breakthroughs in decades But allowing unauthorised manufacturers to mass market GLP-1 knockoffs outside FDA safeguards creates significant patient safety risks and undermines trust in the healthcare system. Safety and innovation concerns The report cites concerns including poor storage, dosing errors, questionable ingredient sourcing and counterfeit products
Beneficiaries must meet certain prior authorization criteria For a Part D beneficiary to qualify for coverage, a medical provider must submit with the prescription a prior authorization request that attests the beneficiary meets the following criteria: The GLP-1 drug is prescribed to reduce excess body weight and maintain weight reduction in combination with current and ongoing lifestyle modification including structured nutrition and physical activity consistent with the applicable FDA approved label
No serious adverse events were reported in the early trials, and the safety profile has remained consistent across the larger Phase 3 programs